Abecma, Breyanzi, CARVYKTI, Kymriah, Tecartus, Yeskarta
Kurapa Kwemasero eCAR T: Kubudirira uye Zvinetso
Nhanganyaya Munzvimbo yeoncology, immunotherapy yabuda senzira yekutanga, ichishandisa immune system yemuviri kurwisa mapundu akaipa. Kune akawanda immunotherapeutic nzira, asi Chimeric Antigen Rece.
Breyanzi, Nhoroondo ye Juno Therapeutics, Yakakura B-cell lymphoma, LBCL, rokuchinja
Lisocabtagene maraleucel inotenderwa neFDA kune yechipiri-mutsara kurapwa kwehombe B-cell lymphoma
Chikunguru 2022: Lisocabtagene maraleucel (Breyanzi, Juno Therapeutics, Inc.) yakabvumidzwa neFood and Drug Administration yevarwere vakuru vane hombe B-cell lymphoma (LBCL) vane chirwere cherefractory kune yekutanga-mutsara chemoi.
BMS, Breyanzi, MOTO - T Cell kurapwa, MOTO T-Cell, CART kurapa, USFDA
Breyanzi - Nyowani CAR T-Cell kurapwa kubva kuBMS
Chikunguru 2021: Breyanzi (Lisocabtagene maraleucel; liso-cel), inoveli CD19-inotungamirwa chimeric antigen receptor (CAR) T cell kurapwa yakagadziriswa naBristol Myers Squibb (BMS), yakabvumidzwa neUS Food and Drug Administration (US.